Central Pharmaceutical Joint Stock Company No3 Investor Relations Material
Latest events
Q1 2025
19 May, 2025
Q4 2024
20 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Central Pharmaceutical Joint Stock Company No3
Access all reports
Central Pharmaceutical Joint Stock Company No3 is a Vietnam-based company engaged in the manufacturing and distribution of pharmaceutical products. The company produces a range of medicines including tablets, capsules, powders, and syrups across various therapeutic categories. It also distributes medical equipment, health supplements, and raw pharmaceutical ingredients. Central Pharmaceutical Joint Stock Company No3 serves hospitals, pharmacies, and healthcare institutions within Vietnam. The company is headquartered in Hanoi, Vietnam, and its shares are listed on the HNX.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
DP3
Country
🇻🇳 Vietnam